Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Artelo Biosciences Inc (ARTL)

Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium GlobeNewswire - Wed Jul 9, 6:50AM CDT

ARTL : 23.88 (-16.23%)
Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model GlobeNewswire - Mon Jul 7, 6:45AM CDT

ARTL : 23.88 (-16.23%)
Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain GlobeNewswire - Mon Jun 30, 6:45AM CDT

ARTL : 23.88 (-16.23%)
Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing GlobeNewswire - Thu Jun 26, 7:00AM CDT

ARTL : 23.88 (-16.23%)
Artelo Biosciences Announces Reverse Stock Split GlobeNewswire - Wed Jun 11, 7:30AM CDT

ARTL : 23.88 (-16.23%)
Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study GlobeNewswire - Thu Jun 5, 8:00AM CDT

ARTL : 23.88 (-16.23%)
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression GlobeNewswire - Mon Jun 2, 8:00AM CDT

ARTL : 23.88 (-16.23%)
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results GlobeNewswire - Tue May 13, 7:00AM CDT

ARTL : 23.88 (-16.23%)
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12’s Effectiveness in Treating Psoriasis GlobeNewswire - Mon Apr 28, 7:45AM CDT

ARTL : 23.88 (-16.23%)
New Strong Sell Stocks for April 10th
New Strong Sell Stocks for April 10th Zacks Investment Research - Thu Apr 10, 6:00AM CDT

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:AST SpaceMobile, Inc. ASTS is a cellular broadband network company. The Zacks Consensus Estimate for its current year earnings...

ARTL : 23.88 (-16.23%)
ASEKY : 12.5115 (-1.05%)
ASTS : 45.58 (+3.66%)

Barchart Exclusives

Gold's Bull Run: Seasonal Strength Meets Conflicting COT Report—Are You In? Barchart - Sat Jul 12, 2:47PM CDT
Gold's all-time high $3,509.9! Central banks bought big, but the COT report waves a red flag. Seasonal gains await—Market players, read or regret! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot